Cargando…
eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin
BACKGROUND: Hypoxia and consequent production of vascular endothelial growth factor A (VEGFA) promote blood vessel leakiness and edema in ocular diseases. Anti-VEGFA therapeutics may aggravate hypoxia; therefore, therapy development is needed. METHODS: Oxygen-induced retinopathy was used as a model...
Autores principales: | Ninchoji, Takeshi, Love, Dominic T, Smith, Ross O, Hedlund, Marie, Vestweber, Dietmar, Sessa, William C, Claesson-Welsh, Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087444/ https://www.ncbi.nlm.nih.gov/pubmed/33908348 http://dx.doi.org/10.7554/eLife.64944 |
Ejemplares similares
-
Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin
por: Smith, Ross O, et al.
Publicado: (2020) -
Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src
por: Sjöberg, Elin, et al.
Publicado: (2023) -
Mechanisms Ensuring Endothelial Junction Integrity Beyond VE-Cadherin
por: Duong, Cao Nguyen, et al.
Publicado: (2020) -
Nitric oxide–dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition
por: Chen, Zhenlong, et al.
Publicado: (2012) -
Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin
por: Frye, Maike, et al.
Publicado: (2015)